Introducing Will Pye
13 December 2019 Will Pye joined the SVI Foundation team in September, in a role created to give optimum support and acknowledgment to our existing major donors and to generate new supporters. “I am excited to bring 20…
Fulbright scholar joins SVI
13 December 2019 Hannah Fluhler, a nursing and Honors student from Ball State University in Indiana, has recently joined SVI’s Genome Stability Unit as a Fulbright Scholar. She chose Associate Professor Andrew Deans’ group because of her personal…
Christine Martin Fellowship awarded
13 December 2019 Dr Jacki Heraud-Farlow, from SVI’s Cancer & RNA Biology Laboratory, has been named as the second recipient of the Christine Martin Fellowship, funded by 5point Foundation. The Fellowship has been designed specifically to support an…
Everyone’s Life Matters
13 December 2019 “My name is Lindsay Hodgson; seven years go when I was diagnosed with Parkinson’s disease my life changed forever. It is because of people like you who support the Bionics Institute that I have hope…
Open for emerging business: Frank Lab 2020 accelerator program – Applications close 17th January 2020
Following the successful Hall & Wilcox Frank Lab 2019 program, which helped accelerate a broad range of businesses and entrepreneurs – from rocket engine engineers to contraceptive technology designers, from Neobank developers to social enterprise creators – applications…
4Dx raises $15 Million in heavily oversubscribed pre-IPO
10 December 2019 Melbourne, Australia: Australian medical technology company 4Dx Limited has raised $15 million in a heavily oversubscribed pre-IPO. The funds raised via the unsecured converting note issue will be used to drive 4Dx’s go-to-market strategy by…
Cann Group Limited: Resignation and appointment of Company Secretary and Acting Chief Financial Officer
9 December 2019 Melbourne: – Cann Group Limited (Company) today advises that Ms Geraldine Farrell has been appointed as Company Secretary and Ms Reena Dahiya has been appointed as Acting Chief Financial Officer, effective 6 December 2019. Ms…
Monash receives largest share of federal medical research funding
7 December 2019 Monash University has been awarded more than $76 million in the latest round of National Health and Medical Research Council (NHMRC) funding to conduct vital research. Federal Health Minister, the Hon. Greg Hunt, today announced…
Supercharging cellular immune therapies to combat solid tumours
9 December 2019 Cellular immune therapies are revolutionising cancer treatment and have been especially effective at combating blood cancers; now a team at Peter Mac and Monash Biomedicine Discovery Institute (BDI), led by Professor Tony Tiganis, may have…
Trajan accelerating adoption and growth of microsampling technologies
6 December 2019 Melbourne, Victoria, Australia Trajan Scientific and Medical (Trajan) announce the appointment of two new roles in their expanding Microsampling business to support global adoption of the portfolio. Led by Dr Anne Collins, the Microsampling business…
Trailblazing entrepreneurs on track to commercial success and healthcare impact
6 December 2019 Last night, the very best of our nation’s innovation ecosystem helped promising entrepreneurs strike out towards commercial success and healthcare impact at the MedTech’s Got Talent Challenge Gala Finals. At MedTech’s black-tie night of nights,…
Cymerus™ MSCs Effective in Preclinical Model of Sepsis
5 December 2019 Melbourne, Australia: Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX: CYP), announced today that it has received positive efficacy data from preclinical studies of its Cymerus™ mesenchymal stem cells (MSCs) in a…
